ProACT Post-Approval Study for Stress Urinary Incontinence
This study is looking at the long-term effects of the ProACT Adjustable Continence Therapy for Men device. This device uses two small, adjustable silicone balloons placed surgically to help men with stress urinary incontinence (leaking urine when you cough, sneeze, or exercise). You may be able to join if you are a man at least 50 years old, have stress urinary incontinence, and have had prostate surgery. The study wants to see how often problems like urethral strictures (narrowing of the urethra) or device erosions (when the device wears away tissue) occur over 5 years. It also measures how the device affects your quality of life. The current recruitment status is unclear.
- Study design
- This is a 5-year, open-label study across multiple centers, planning to enroll 145 participants.
- What's involved
- You would undergo surgical implantation of the ProACT devices and be followed for 5 years.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 5 years after the ProACT implantation.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
ProACT Post-Approval Study
At a glance
Conditions
Where it's being run
6 sites across 6 statesStudy leadership
- Timothy C Cook, PhD · STUDY_DIRECTOR · Uromedica, Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Urethral Strictures5 years
Cumulative incidence of ProACT-related clinically relevant urethral strictures over 5 years of follow up.
- Device Erosions5 years
Cumulative incidence of ProACT device erosions over 5 years of follow-up.
- Incontinence Quality of Life Questionnaire (I-QoL)5 years
Results on Validated Incontinence Quality of Life Questionnaire